Afuco™ Anti-Human TRO ADCC Therapeutic Antibody, ADCC Enhanced
Anti-TRO ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-KIAA1114 antibody specifically binds to an extracellular domain of a KIAA1114 protein, specifically reacts with various cancer cell lines and remarkably represses metastasis of cancer in vivo in a lung metastasis animal model using a KIAA1114 over-expression cancer cell line. Therefore, the anti-KIAA1114 antibody can be effectively used for the prevention or treatment of cancer- particularly metastatic cancer, which is caused by KIAA1114 over-expression.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-622CL |
| Pricing | Inquiry |
| Host | Human |
| Target | TRO |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Can be stored at 4°C. For long term storage, aliquot and store at -20°C. Avoid repeated freezing and thawing cycles. |